Here are the top Institutional holders of Omnicell, Inc. (OMCL) shares

Omnicell, Inc. (NASDAQ: OMCL) is -22.67% lower on its value in year-to-date trading and has touched a low of $28.72 and a high of $77.14 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The OMCL stock was last observed hovering at around $32.46 in the last trading session, with the day’s loss setting it -3.36%.

Currently trading at $29.10, the stock is -12.71% and -16.93% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 2.06 million and changing -10.35% at the moment leaves the stock -43.82% off its SMA200. OMCL registered -50.05% loss for a year compared to 6-month loss of -55.55%. The firm has a 50-day simple moving average (SMA 50) of $1.25 and a 200-day simple moving average (SMA200) of $31.76.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.

The stock witnessed a -16.50% gain in the last 1 month and extending the period to 3 months gives it a -5.49%, and is -10.46% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 5.25% over the week and 4.02% over the month.

Omnicell, Inc. (OMCL) has around 4230 employees, a market worth around $1.32B and $1.15B in sales. Fwd P/E is 20.35. Profit margin for the company is -1.78%. Distance from 52-week low is 1.32% and -62.27% from its 52-week high. The company has generated returns on investments over the last 12 months (-1.14%).

Omnicell, Inc. quarterly earnings per share for the current quarter are estimated at $0.15 with sales reaching $255.56M over the same period.The EPS is expected to shrink by -31.81% this year, but quarterly earnings will post -11.90% year-over-year. Quarterly sales are estimated to shrink -14.20% in year-over-year returns.

424 institutions hold shares in Omnicell, Inc. (OMCL), with institutional investors hold 104.50% of the company’s shares. The shares outstanding are 44.75M, and float is at 44.60M with Short Float at 4.74%. Institutions hold 102.90% of the Float.

The top institutional shareholder in the company is Blackrock Inc. with over 6.01 million shares valued at $443.11 million. The investor’s holdings represent 13.30% of the OMCL Shares outstanding. As of Jun 29, 2023, the second largest holder is Vanguard Group Inc with 4.46 million shares valued at $328.73 million to account for 9.87% of the shares outstanding. The other top investors are Wellington Management Group, LLP which holds 3.83 million shares representing 8.47% and valued at over $282.11 million, while State Street Corporation holds 3.77% of the shares totaling 1.71 million with a market value of $125.69 million.

Omnicell, Inc. (OMCL) Insider Activity

A total of 6 insider transactions have happened at Omnicell, Inc. (OMCL) in the last six months, with sales accounting for 4 and purchases happening 2 times. The most recent transaction is an insider sale by MELLON CHRISTINE MARIE, the company’s EVP, EXECUTIVE ADVISOR. SEC filings show that MELLON CHRISTINE MARIE sold 7,951 shares of the company’s common stock on Jun 09 at a price of $73.14 per share for a total of $0.58 million. Following the sale, the insider now owns 14876.0 shares.

Omnicell, Inc. disclosed in a document filed with the SEC on Jun 08 that LIPPS RANDALL A (CHAIRMAN, PRESIDENT AND CEO) bought a total of 4,000 shares of the company’s common stock. The trade occurred on Jun 08 and was made at $73.76 per share for $0.3 million. Following the transaction, the insider now directly holds 0.32 million shares of the OMCL stock.

Still, SEC filings show that on Mar 07, Bauer Joanne B (Director) disposed off 13,115 shares at an average price of $54.24 for $0.71 million. The insider now directly holds 28,096 shares of Omnicell, Inc. (OMCL).

Omnicell, Inc. (OMCL): Who are the competitors?

One of the company’s main competitors (and peers) include Premier Inc. (PINC) that is trading -35.05% down over the past 12 months.Cencora Inc. (COR) lies in the list of competitors of the Omnicell, Inc. and is 44.83% higher over the same period from OMCLCardinal Health Inc. (CAH) is 28.69% up on the 1-year trading charts.